Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels - PubMed (original) (raw)
Randomized Controlled Trial
. 2007 Nov;30(11):2945-50.
doi: 10.2337/dc07-0768. Epub 2007 Aug 8.
Affiliations
- PMID: 17686833
- DOI: 10.2337/dc07-0768
Randomized Controlled Trial
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels
Theodore W K Ng et al. Diabetes Care. 2007 Nov.
Abstract
Objective: The purpose of this study was to examine the effect of weight loss on LDL and HDL kinetics and plasma retinol-binding protein-4 (RBP-4) and adiponectin levels in men with the metabolic syndrome.
Research design and methods: LDL apolipoprotein (apo)B-100 and HDL apoA-I kinetics were studied in 35 obese men with the metabolic syndrome at the start and end of a 16-week intervention trial of a hypocaloric, low-fat diet (n = 20) versus a weight maintenance diet (n = 15) using a stable isotope technique and multicompartmental modeling.
Results: Consumption of the low-fat diet produced significant reductions (P < 0.01) in BMI, abdominal fat compartments, and homeostasis model assessment score compared with weight maintenance. These were associated with a significant increase in adiponectin and a fall in plasma RBP-4, triglycerides, LDL cholesterol, and LDL apoB-100 concentration (P < 0.05). Weight loss significantly increased the catabolism of LDL apoB-100 (+27%, P < 0.05) but did not affect production; it also decreased both the catabolic (-13%) and production (-13%) rates of HDL apoA-I (P < 0.05), thereby not altering plasma HDL apoA-I or HDL cholesterol concentrations. VLDL apoB-100 production fell significantly with weight loss (P < 0.05). The increase in LDL catabolism was inversely correlated with the fall in RBP-4 (r = -0.54, P < 0.05) and the decrease in HDL catabolism with the rise in adiponectin (r = -0.56, P < 0.01).
Conclusions: In obese men with metabolic syndrome, weight loss with a low-fat diet decreases the plasma LDL apoB-100 concentration by increasing the catabolism of LDL apoB-100; weight loss also delays the catabolism of HDL apoA-I with a concomitant reduction in the secretion of HDL apoA-I. These effects of weight loss could partly involve changes in RBP-4 and adiponectin levels.
Similar articles
- Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndrome.
Ng TW, Chan DC, Barrett PH, Watts GF. Ng TW, et al. Clin Sci (Lond). 2009 Oct 2;118(1):79-85. doi: 10.1042/CS20090110. Clin Sci (Lond). 2009. PMID: 19456294 Free PMC article. Clinical Trial. - Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
Chan DC, Watts GF, Ng TW, Yamashita S, Barrett PH. Chan DC, et al. Eur J Clin Invest. 2008 Oct;38(10):743-51. doi: 10.1111/j.1365-2362.2008.02019.x. Eur J Clin Invest. 2008. PMID: 18837799 Clinical Trial. - Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
Chan DC, Barrett PH, Ooi EM, Ji J, Chan DT, Watts GF. Chan DC, et al. J Clin Endocrinol Metab. 2009 Mar;94(3):989-97. doi: 10.1210/jc.2008-1457. Epub 2008 Dec 30. J Clin Endocrinol Metab. 2009. PMID: 19116237 - Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.
Watts GF, Chan DC, Ooi EM, Nestel PJ, Beilin LJ, Barrett PH. Watts GF, et al. Clin Exp Pharmacol Physiol. 2006 Sep;33(9):877-82. doi: 10.1111/j.1440-1681.2006.04458.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16922825 Review. - Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods.
Chan DC, Barrett PH, Watts GF. Chan DC, et al. Clin Sci (Lond). 2004 Sep;107(3):233-49. doi: 10.1042/CS20040109. Clin Sci (Lond). 2004. PMID: 15225143 Review.
Cited by
- Association between Weight Change and Incidence of Dyslipidemia in Young Adults: A Retrospective Cohort Study of Korean Male Soldiers.
Yoon JY, Park WJ, Kim HK, Kang HC, Park CK, Choi W. Yoon JY, et al. J Obes Metab Syndr. 2024 Mar 30;33(1):36-44. doi: 10.7570/jomes23056. Epub 2024 Jan 22. J Obes Metab Syndr. 2024. PMID: 38246603 Free PMC article. - Associations of retinol-binding protein 4 with oxidative stress, inflammatory markers, and metabolic syndrome in a middle-aged and elderly Chinese population.
Liu Y, Wang D, Li D, Sun R, Xia M. Liu Y, et al. Diabetol Metab Syndr. 2014 Feb 24;6(1):25. doi: 10.1186/1758-5996-6-25. Diabetol Metab Syndr. 2014. PMID: 24559154 Free PMC article. - Atherogenic dyslipidemia and combination pharmacotherapy in diabetes: recent clinical trials.
Hamilton SJ, Watts GF. Hamilton SJ, et al. Rev Diabet Stud. 2013 Summer-Fall;10(2-3):191-203. doi: 10.1900/RDS.2013.10.191. Epub 2013 Aug 10. Rev Diabet Stud. 2013. PMID: 24380092 Free PMC article. Review. - The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study.
Mazokopakis EE, Papadomanolaki MG, Fousteris AA, Kotsiris DA, Lampadakis IM, Ganotakis ES. Mazokopakis EE, et al. Ann Gastroenterol. 2014;27(4):387-394. Ann Gastroenterol. 2014. PMID: 25331487 Free PMC article. - Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome.
Richard C, Couture P, Desroches S, Lichtenstein AH, Lamarche B. Richard C, et al. J Lipid Res. 2013 Jan;54(1):232-7. doi: 10.1194/jlr.M029934. Epub 2012 Nov 2. J Lipid Res. 2013. PMID: 23125458 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous